TMPRSS2 : ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer

KGL Hermans; Ronald van Marion; H (Herman) van Dekken; Guido Jenster; Wytske van Weerden; Jan Trapman

TMPRSS2 : ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer

KGL Hermans, Ronald van Marion, H (Herman) van Dekken, Guido Jenster, Wytske van Weerden, Jan Trapman

Research output: Contribution to journal › Article › Academic › peer-review

189 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	10658-10663
Number of pages	6
Journal	Cancer Research
Volume	66
Issue number	22
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{0f00a4d134db4bd4874992e3c0170859,

title = "TMPRSS2 : ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer",

author = "KGL Hermans and {van Marion}, Ronald and {van Dekken}, {H (Herman)} and Guido Jenster and {van Weerden}, Wytske and Jan Trapman",

year = "2006",

language = "Undefined/Unknown",

volume = "66",

pages = "10658--10663",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "22",

}

TMPRSS2 : ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. / Hermans, KGL; van Marion, Ronald; van Dekken, H (Herman) et al.
In: Cancer Research, Vol. 66, No. 22, 2006, p. 10658-10663.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - TMPRSS2 : ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer

AU - Hermans, KGL

AU - van Marion, Ronald

AU - van Dekken, H (Herman)

AU - Jenster, Guido

AU - van Weerden, Wytske

AU - Trapman, Jan

PY - 2006

Y1 - 2006

M3 - Article

SN - 0008-5472

VL - 66

SP - 10658

EP - 10663

JO - Cancer Research

JF - Cancer Research

IS - 22

ER -